Some Zoonotic Antigens May Help Combat Unknown Pathogens: Forming the Puzzle from the Evidences in the COVID Era
Overview
Overview
Journal
Infect Disord Drug Targets
Publisher
Bentham Science Publishers
Specialty
Infectious Diseases
Date
2024 Apr 30
PMID
38685779
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Temmam S, Barbarino A, Maso D, Behillil S, Enouf V, Huon C
. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus. One Health. 2020; 10:100164.
PMC: 7455794.
DOI: 10.1016/j.onehlt.2020.100164.
View
2.
Villanueva-Saz S, Giner J, Fernandez A, Lacasta D, Ortin A, Ramos J
. Absence of SARS-CoV-2 Antibodies in Natural Environment Exposure in Sheep in Close Contact with Humans. Animals (Basel). 2021; 11(7).
PMC: 8300300.
DOI: 10.3390/ani11071984.
View
3.
Bhattacharya M, Chatterjee S, Lee S, Chakraborty C
. Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update. Int J Biol Macromol. 2022; 229:70-80.
PMC: 9797221.
DOI: 10.1016/j.ijbiomac.2022.12.284.
View
4.
Xu J, Xu K, Jung S, Conte A, Lieberman J, Muecksch F
. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021; 595(7866):278-282.
PMC: 8260353.
DOI: 10.1038/s41586-021-03676-z.
View
5.
Botosso V, Attie Calil Jorge S, Mancini Astray R, Guimaraes A, Mathor M, de Carneiro P
. Anti-SARS-CoV-2 equine F (Ab') immunoglobulin as a possible therapy for COVID-19. Sci Rep. 2022; 12(1):3890.
PMC: 8913704.
DOI: 10.1038/s41598-022-07793-1.
View